The role(s) of the novel stargazin-like ␥-subunit proteins remain controversial. We have shown previously that the neuron-specific ␥7 suppresses the expression of certain calcium channels, particularly Ca V 2.2, and is therefore unlikely to operate as a calcium channel subunit. We now show that the effect of ␥7 on Ca V 2.2 expression is via an increase in the degradation rate of Ca V 2.2 mRNA and hence a reduction of Ca V 2.2 protein level. Furthermore, exogenous expression of ␥7 in PC12 cells also decreased the endogenous Ca V 2.2 mRNA level. Conversely, knockdown of endogenous ␥7 with short-hairpin RNAs produced a reciprocal enhancement of Ca V 2.2 mRNA stability and an increase in endogenous calcium currents in PC12 cells. Moreover, both endogenous and expressed ␥7 are present on intracellular membranes, rather than the plasma membrane. The cytoplasmic C terminus of ␥7 is essential for all its effects, and we show that ␥7 binds directly via its C terminus to a heterogeneous nuclear ribonucleoprotein (hnRNP A2), which also binds to a motif in Ca V 2.2 mRNA, and is associated with native Ca V 2.2 mRNA in PC12 cells. The expression of hnRNP A2 enhances Ca V 2.2 I Ba , and this enhancement is prevented by a concentration of ␥7 that alone has no effect on I Ba . The effect of ␥7 is selective for certain mRNAs because it had no effect on ␣2␦-2 mRNA stability, but it decreased the mRNA stability for the potassium-chloride cotransporter, KCC1, which contains a similar hnRNP A2 binding motif to that in Ca V 2.2 mRNA. Our results indicate that ␥7 plays a role in stabilizing Ca V 2.2 mRNA.
Introduction
Voltage-dependent calcium channels (Ca V ) are heteromultimers consisting of a pore-forming ␣1 subunit, assembled with auxiliary ␤, ␣2␦, and possibly ␥ subunits (for review, see Catterall, 2000; Dolphin, 2003a,b) . The role(s) of the ␥ subunits in relation to calcium channel function remains unclear. The first Ca V ␥ subunit to be identified was ␥1, which copurifies with the skeletal muscle calcium channel complex (Jay et al., 1991; Powers et al., 1993) . In skeletal muscle, the ␥1 subunit appears to have a suppressive effect, because ␥1 knock-out mice exhibit increased skeletal muscle calcium currents (Freise et al., 2000) . After the identification of stargazin (␥2) (Letts et al., 1998) , subsequent studies have identified six additional putative ␥ subunits (␥3-␥8) (Black and Lennon, 1999; Burgess et al., 1999 Burgess et al., , 2001 Klugbauer et al., 2000; Moss et al., 2002) . However, it is unclear whether any of these novel stargazin-like ␥ proteins (␥2-␥8) play any role as subunits of voltage-gated calcium channels. All members of this family are thought to possess four transmembranespanning domains with intracellular N and C termini. The ␥2, ␥3, ␥4, and ␥8 subunits form a subfamily exclusively localized to the CNS (Letts et al., 1998; Klugbauer et al., 2000; Sharp et al., 2001; Moss et al., 2003) whose interaction and functional modulation of Ca V channels has been investigated in several studies (Letts et al., 1998; Klugbauer et al., 2000; Kang et al., 2001; Rousset et al., 2001; Sharp et al., 2001; Moss et al., 2003) but which are now thought primarily to represent trafficking proteins for the AMPA subtype of glutamate receptors (TARPS) (Tomita et al., 2003 (Tomita et al., , 2004 . However, they might also provide a bridge between calcium channels and AMPA receptors (Kang et al., 2006) . Furthermore, ␥7, despite not having a classical C-terminal PDZ (postsynaptic density-95/Discs large/zona occludens-1) binding domain, has also been shown recently to have effects on AMPA receptor trafficking (Kato et al., 2007) .
The ␥7 and ␥5 proteins are predicted to represent a distinct ability to knockdown c-jun (supplemental Fig. 1 , available at www. jneurosci.org as supplemental material). Antibodies against ␥7. The ␥7 tail polyclonal rabbit antibody (Ab) raised against the C-terminal peptide YPPAIKYPDHLHIS has been described previously . A ␥7 loop Ab was also raised against the peptide VASEYFLEPEINLVTEN, in the loop between transmembrane segments 1 and 2 of ␥7. These Abs do not recognize any of the other ␥ proteins tested (␥2-␥4) (supplemental Fig. 2 A-C, available at www.jneurosci.org as supplemental material).
Cell culture and transfection. COS-7 cells were cultured as described previously (Campbell et al., 1995) . The tsA 201 cells were cultured in DMEM with 10% fetal bovine serum (FBS) and 1% L-glutamine. Cells were transfected using either Geneporter (Qbiogene) or Fugene6 (Roche Diagnostics), with equivalent results. The cDNAs (all at 1 g/l) for Ca V ␣1, ␣ 2 ␦-2, ␤1b, ␥7, and GFP when used as a reporter of transfected cells, were mixed in a ratio of 3:1.5:2:1.5:1:0.2, unless otherwise stated. When particular subunits were not used, the volume was made up with Tris-EDTA (10 mM Tris and 1 mM EDTA, pH 7), or blank vector, or the volume of transfection reagent was reduced, with equivalent results. In some experiments, cDNA for the nonconducting potassium channel Kir2.1-AAA (Tinker et al., 1996) was used as control for the presence of ␥7, also with equivalent results to the use of blank vector.
PC12 cells were grown in DMEM, 7.5% FBS, and 7.5% horse serum. For electrophysiology, PC12 cells were transiently transfected with cDNAs for GFP and/or ␥7, using Fugene6. Differentiation was with serumfree medium containing NGF (100 ng/ml murine 7s NGF; Invitrogen), replenished every 48 h. Cells were used for recording after 5-7 d of differentiation. For the generation of stable cell lines, PC12 cells were transfected with ␥7-HA or ␥7-CFP, and clonal cell lines were established by standard techniques, using 400 g/ml Geneticin (Invitrogen) for selection. The culture medium was subsequently supplemented with 400 g/ml Geneticin (Invitrogen).
To obtain high transfection rates with shRNAs, PC12 cells were transfected using an Amaxa Nucleofector, according to manufacturer instructions. The DNA mix contained 2 g of shRNA plasmid and 0.5 g of GFP or yellow fluorescent protein (YFP) as a reporter of transfected cells. Cells were used 4 -5 d after transfection with shRNA.
For primary culture of superior cervical ganglion (SCG) neurons, rats were killed by either CO 2 inhalation or cervical dislocation, according to United Kingdom Home Office Schedule 1 Guidelines. SCGs were dissected from rats at postnatal day 17. Ganglia were desheathed and lightly gashed before successive collagenase (Sigma) and trypsin (Sigma) treatment, both at 3 mg/ml. To produce a single-cell suspension, ganglia were dissociated by trituration and centrifugation. Dissociated cells were plated onto glass-bottomed plates (MatTek) precoated with laminin (Sigma), using one ganglion per five plates. Cells were maintained with Liebovitz L-15 medium (Sigma), supplemented with 24 mM NaHCO 3 , 10% FBS (Invitrogen), 33 mM glucose (Sigma), 20 mM L-glutamine, 1000 IU of penicillin, 1000 IU of streptomycin (Invitrogen), and 50 ng/ml NGF.
Microinjection. cDNAs were injected into SCG neurons 18 -24 h after they were placed in culture. Microinjection was performed using an Eppendorf microinjection system on a Carl Zeiss Axiovert 200M microscope using the following settings: 100 -150 hPa injection pressure, an injection time of 0.2 s, and constant pressure of between 40 and 50 hPa. The cDNAs were injected at 50 ng/l diluted in 200 mM KCl.
Measurement of mRNA levels by quantitative PCR. RNA was isolated using RNeasy columns (Qiagen), including an on-column DNase step. Reverse transcription (RT) was performed using random hexamer primers and Moloney murine leukemia virus reverse transcriptase (Promega) at 37°C for 2 h. The quantitative PCR (q-PCR) was performed with an iCycler (Bio-Rad) using the iQ SYBR supermix. For each set of primers and for every experiment, a standard curve was generated using a serial dilution of reverse-transcribed RNA combined from several samples. For q-PCR in PC12 cells, the following primers were used: rat Ca V 2.2 (GenBank accession number NM147141), 5Ј-GGCAAGAAGGAGGCAGAG-3Ј and 5Ј-GCAGAAGCGACGGAGTAG-3Ј; rat ␥7 (GenBank accession number AF361345), 5Ј-CTACTCGGGCCAGTTTCTGC-3Ј and 5Ј-GC-CGGAGGGTAATTTTGC-3Ј; and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (GenBank accession number AF106860), 5Ј- Figure 1 . Effect of C-terminal truncation of ␥7 on Ca V 2.2/␤1b/␣2␦-2 and Ca V 3.1 currents. A, Linearized diagram of ␥7, indicating the approximate positions of the four transmembrane (TM) segments (black bars), the N-glycosylation site (V) at N45, and the position of the truncations at amino acids 217, 238, and 271. B, Left, Example traces elicited after cDNA injection into Xenopus oocytes by 100 ms step depolarizations to between Ϫ40 and 0 mV from a holding potential of Ϫ100 mV for Ca V 2.2/ ␤1b/␣2␦-2 (top), plus ␥7 (middle) and plus ␥7 (1-217) (bottom). The charge carrier was 10 mM Ba 2ϩ . The symbols beside the traces refer to the relevant data in the current-voltage relationship (right); Ca V 2.2/␤1b/␣2␦-2 (f; n ϭ 19) plus ␥7(1-217) (‚; n ϭ 18) and plus ␥7 (Ⅺ; n ϭ 8). Data are fit by a modified Boltzmann function as described in Materials and Methods, with V 50, act of Ϫ9.9, Ϫ9.8, and ϩ1.2 mV, respectively, and G max of 19.6, 16.6, and 5.9 S, respectively. C, Mean percentage of control peak I Ba for Ca V 2.2/␤1b/␣2␦-2 currents (black bar; n ϭ 29) when coexpressed with ␥7 (white bar; n ϭ 31) or its truncated constructs, ␥7(1-217) (hatched bar; n ϭ 15), ␥7(1-238) (gray bar; n ϭ 12), and ␥7(1-271) (striped bar; n ϭ 16). The statistical significances compared with control are **p Ͻ 0.01. There was no effect of any of the constructs on the voltage for 50% steady-state inactivation, which from combined experiments was Ϫ60.2 Ϯ 0.8 mV for controls (n ϭ 16), Ϫ58.6 Ϯ 1.0 mV in the presence of ␥7 (n ϭ 7), Ϫ61.7 Ϯ 3.6 mV for ␥7(1-217) (n ϭ 5), and Ϫ59.8 Ϯ 1.0 mV for ␥7(1-271) (n ϭ 5). D, Representative traces of peak Ba 2ϩ currents in tsA 201 cells, cotransfected with Ca V 2.2, ␤1b and ␣2␦-2 with pMT2 as control (con) compared with ␥7 (panel 1), ␥7(1-217) (panel 2), and ␥7(stop) (panel 3). Panel 4 shows Ca V 3.1 expression with pMT2 as control (con) compared with ␥7. Currents were elicited by depolarization to ϩ5 mV (Ca V 2.2, 1 mM Ba 2ϩ ) or Ϫ10 mV (Ca V 3.1, 10 mM Ba 2ϩ ), from a holding potential of Ϫ100 mV. Calibration bars refer to all traces for Ca V 2.2. E, Mean inhibition of Ba 2ϩ currents (expressed as percentage of control Ϯ SEM) induced by coexpression of Ca V 2.2 with ␥7 (white bar; n ϭ 21), ␥7(1-217) (black bar; n ϭ 15), ␥7(stop) (hatched bar; n ϭ 28), or Ca V 3.1 with ␥7 (cross-hatched bar; n ϭ 29). Statistical significance compared with the current size without ␥7, **p Ͻ 0.01, Student's t test.
incubated for 2 h at 4°C with constant agitation. Beads were washed twice with a high detergent buffer (1% Igepal, 20 mM Tris, 150 mM NaCl, 1 mM EDTA, and protease inhibitor cocktail, pH 7.4), twice with a high-salt buffer (0.1% Igepal, 20 mM Tris, 500 mM NaCl, 1 mM EDTA, and protease inhibitor cocktail, pH 7.4), and twice with a low-salt buffer (0.1% Igepal, 20 mM Tris, 1 mM EDTA, and protease inhibitor cocktail, pH 7.4). Bound protein was removed from the beads by the addition of lauryl dodecyl sulfate (LDS) sample buffer with reducing agent (Invitrogen) and heating to 65°C for 10 min. Samples containing immunoprecipitated endogenous ␥7 were treated with LDS buffer as above and eluted proteins concentrated by precipitation with ice-cold acetone before resuspension in fresh LDS buffer for PAGE. For protein sequencing, samples were separated on 4 -12% Bis-Tris gels (Invitrogen) and stained with Coomassie blue (Simply Safe Blue stain; Invitrogen). Bands of interest were excised from the gel, and protein identification was performed by the Imperial College Proteomics Facility by tryptic mass fingerprinting, confirmed by tandem mass spectrometry. The controls were from nontransfected cells, treated identically.
Coimmunoprecipitation of RNAs associated with hnRNP A2. PC12 cells were lysed and protein solubilized by agitation with extraction buffer containing 1% Igepal, 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, and protease inhibitor cocktail, pH 7.4, supplemented with 5 U/ml RNAguard (GE Healthcare), for 30 min at 4°C. Samples were centrifuged (50,000 ϫ g, 1 h at 4°C), and the corresponding supernatant was then precleared with 50 g of protein G-Sepharose. The supernatant was divided into two and either incubated with 2 g/ml high-affinity anti-HA Ab or an equivalent volume of PBS overnight at 4°C with constant agitation. An additional 20 g of protein G-Sepharose was added and incubated for 2 h at 4°C with constant agitation. Beads were washed six times by centrifugation as described in the previous section, except that the wash buffers were supplemented with 5 U/ml RNAguard. A small aliquot of beads was removed for protein analysis. The RNA on the remaining beads was extracted with Trizol (Invitrogen). Total RNA was reverse transcribed with SuperScript III (Invitrogen) using random primers. PCR was performed using the primers described above.
Western blotting. Cells were processed for SDS-PAGE as described previously (Raghib et al., 2001) . For detection of endogenous ␥7 in PC12 cells, cells were lysed on ice by sonication three times for 10 s and centrifuged at 3000 ϫ g for 3 min. This supernatant was decanted and centrifuged at 50,000 ϫ g for 4 h at 4°C. The high-speed supernatant and membrane-containing pellet were then taken up in SDS buffer. Samples (50 g of cell lysate protein per lane) or immunoprecipitation samples prepared as above were separated using Novex 4 -12% Tris-glycine or 4 -12% Bis-Tris NuPAGE gels (Invitrogen) and transferred electrophoretically to polyvinylidene fluoride membranes. The membranes were blocked with 3% BSA/0.02% Tween 20 and then incubated overnight at room temperature with the relevant primary Ab: rabbit antihnRNP A/B Ab (H-200; 1:1000; Autogen Bioclear or Santa Cruz Biotechnology); anti-hnRNP A/B monoclonal Ab (F16; 1:1000; Autogen Bioclear); anti-hnRNP A2 monoclonal Ab [EF-67; 1:1000 (Nichols et al., 2000) ]; rabbit anti-HA Ab (1:1000; Sigma), affinity-purified anti-␥7 Ab (0.4 g/ml), or anti-␣2␦-2(102-117) (1 g/ml) (Brodbeck et al., 2002) . The ␥2-␥4 Abs have been described previously (Moss et al., 2003) . Detection was performed using anti-rabbit or anti-mouse secondary Ab conjugated to HRP (1 g/ml; Bio-Rad), and bound Abs were detected using enhanced chemiluminescence (ECL) or ECLPlus reagents (GE Healthcare). Chemiluminescence or fluorescence was detected using a Typhoon 9410 Variable Mode Imager (GE Healthcare), set in chemiluminescence or fluorescence mode, respectively. Protein bands were quantified using Imagequant 5.2, on nonsaturated images.
Immunocytochemistry. Cells were fixed and permeabilized for immunocytochemistry essentially as described previously (Brice et al., 1997) . The primary Abs used were affinity-purified anti-␥7 loop or tail Ab (as stated, 0.8 g/ml) and mouse monoclonal anti-protein disulfide isomerase (1:100; Abcam). Alexa Fluor 594 -phalloidin (Invitrogen) was also used. Secondary Texas Red, FITC, or biotin-conjugated goat anti-mouse (Invitrogen) or goat anti-rabbit (Sigma) Abs were applied at 10 and 5 g/ml, respectively. When used, Texas Red-or FITC-conjugated streptavidin were applied at 3.33 g/ml. A cyanine 3-tyramide signal amplification kit (PerkinElmer Life and Analytical Sciences) was used to detect ␥7 in SCG neurons. In some experiments, the nuclear dye 4Ј,6-diamidino-2-phenylindole (DAPI) (300 nM; Invitrogen) was also used to visualize the nucleus. Cells were mounted in Vectashield (Vector Laboratories) to reduce photobleaching and examined on a confocal laser scanning microscope (Leica TCS SP or Carl Zeiss LSM), using a 40ϫ (1.3 numerical aperture) or 63ϫ (1.4 numerical aperture) oil-immersion objective. Optical sections were 1.5 m. Photomultiplier settings were kept constant in each experiment, and all images were scanned sequentially. In some experiments, when stated, a conventional fluorescence microscope Figure 2 . Effect of C-terminal truncation of ␥7 on Ca V 2.2 protein. A, ␥7 and truncated ␥7 constructs were expressed at the expected sizes in COS-7 cells (top, ␥7 I-II loop Ab; bottom ␥7, C-terminal tail Ab). In each lane, the lower band corresponds to the expected protein molecular weight, and the upper band(s) correspond to either the mature glycosylated form or intermediate glycosylated species. As expected, ␥7(1-217) and ␥7(1-238) were not detected by the ␥7(C-terminal tail) Ab. The specificity of the Abs is indicated by the lack of immunostaining in the absence of transfected constructs (Ϫ). Similar results were obtained in Xenopus oocytes (data not shown). The same amount of total protein was loaded in each lane (25 g). B, Examples of Western blots showing the effect of ␥7(i) and ␥7(1-271) (ii) and the lack of effect of ␥7(1-217) (iii) and K V 3.1b (iv) on the level of Ca V 2.2 protein expressed in COS-7 cells. con, Transfection with Kir-AAA cDNA, in place of ␥7 (see Materials and Methods). The same amount of total protein was loaded in each pair of lanes (25 g). C, Correlation between the effect of the ␥7 and its various C-terminal truncated constructs on the level of Ca V 2.2 protein with their effect on Ca V 2.2 I Ba shown in Figure 1C . The effect of ␥7, ␥7(1-217), ␥7(1-271), and ␥7(1-238) on Ca V 2.2 protein levels represents the mean inhibition observed in 3-10 experiments. The linear fit has a correlation coefficient, r, of 0.936. All error bars are SEM.
(Axiovert 200; Carl Zeiss) and CCD camera was used; images were captured using Volocity software (Improvision).
Image processing was performed using NIH ImageJ (http://rsb.info. nih.gov/ij/). Colocalization analysis was performed using the colocalization plugin on images converted to 8 bit. Fluorophores are considered as colocalized in each pixel when their respective intensities are higher than the threshold (50) of their channels and when their intensity ratio is Ͼ50%.
Electrophysiology. Xenopus oocytes were prepared, injected, and used for electrophysiology as described previously (Cantí et al., 1999) , with the following exceptions. Plasmid cDNAs for the different voltagedependent calcium channel subunits ␣1, ␣2␦-2, ␤1b, and other constructs such as ␥7 were mixed in equivalent weight ratios at 1 g/l, unless otherwise stated, and 9 nl was injected intranuclearly, after appropriate dilution. The recording solution for Ca V 2.2-injected oocytes contained the following (in mM): 10 Ba(OH) 2 , 80 tetraethylammonium-OH, 2 CsOH, and 5 HEPES, pH 7.4 with methanesulfonic acid.
Whole-cell patch-clamp recording using tsA 201 or PC12 cells was performed and analyzed as described previously (Meir et al., 2000) , with 1 mM Ba 2ϩ as charge carrier (unless stated) and a holding potential of Ϫ100 mV. Currents were measured 10 ms after the onset of the test pulse, and the average over a 2 ms period was calculated and used for analysis. Data are expressed as mean Ϯ SEM, and I-V plots were fit with a modified Boltzmann equation as described previously (Cantí et al., 2001) .
Results
The reduction of functional Ca V 2.2 protein by ␥7 is mediated via the C terminus of ␥7 These experiments were initiated in the light of our previous finding that coexpression of ␥7 reduced Ca V 2.2 protein level, as well as its functional expression . We have now dissected the region of ␥7 responsible for the inhibitory effect by making constructs lacking most or part of the cytoplasmic C terminus, ␥7(1-217) and ␥7(1-238) (Fig. 1 A) . After cDNA injection in Xenopus oocytes, when full-length ␥7 was coexpressed with Ca V 2.2, it produced ϳ90% suppression of Ca V 2.2 currents ( Fig. 1 B, C) . In contrast, the shorter ␥7(1-217) transmembrane construct had very little influence on the expression of Ca V 2.2 currents ( Fig. 1 B, C) , whereas the ␥7(1-238) construct produced a partial reduction of the Ca V 2.2 current (Fig. 1C) . The C-terminal motif (T/S-SPC) is conserved between ␥7 and ␥5. Although this does not represent a classical PDZ binding motif, we investigated the importance of this epitope in mediating the effects of ␥7 on Ca V 2.2 currents. A construct lacking these four amino acids [␥7(1-271)] was as effective as ␥7 in reducing Ca V 2.2 I Ba (Fig. 1C ), indicating that this motif is not involved in the effect of ␥7. Furthermore, addition of a C-terminal tag, such as HA or CFP, did not affect the ability of ␥7 to suppress the expression of Ca V 2.2 currents. For ␥7-HA, 72.5 Ϯ 10.1% (n ϭ 5) inhibition of Ca V 2.2 currents was observed. These results indicate that a region of the ␥7 C terminus between R217 and S271 is responsible for inhibiting Ca V 2.2 expression.
The role of the C terminus of ␥7 was confirmed in tsA 201 cells. Here again the truncated ␥7(1-217) produced no inhibition of Ca V 2.2 currents (5.1 Ϯ 18.6%) ( Fig. 1 D, E) , whereas fulllength ␥7 produced 94.9 Ϯ 18.6% inhibition ( Fig. 1 D, E) . To confirm that the ␥7 protein was responsible for this effect, we showed that a ␥7 construct containing a stop codon before the first transmembrane domain produced no inhibition ( Fig.  1 D, E) . Furthermore, in contrast to the effect of ␥7 on Ca V 2.2 currents, it had no significant effect on Ca V 3.1 currents ( Fig.  1 D 
, E).
We raised two antipeptide Abs against ␥7, to unique peptides in the linker between transmembrane segments I and II, and in the C terminus. Neither Ab recognized any protein bands in untransfected COS-7 cells (Fig. 2 A) , and neither Ab cross-reacted with other ␥ proteins tested (supplemental Fig. 2 A-C, available at www.jneurosci.org as supplemental material). We then confirmed that the truncated ␥7 constructs were all expressed at a similar level to full-length ␥7 and that the truncated constructs were of the expected size (Fig. 2 A) . Next, we examined the effect of ␥7 and its C-terminal truncations on the level of Ca V 2.2 pro- Effect of ␥7 and C-terminally truncated ␥7(1-217) on Ca V 2.2 mRNA stability. A, Effect of ␥7 on Ca V 2.2 mRNA degradation rate. Constructs were expressed in Xenopus oocytes either without (f) or with ␥7(‚) or with ␥7(1-217) (Ⅺ). In the absence of a ␥7 construct, an equivalent amount of a similar sized transcript, a nonfunctional K ϩ channel Kir-AAA cDNA was used. After 24 h (T 0 ), actinomycin D (50 g/ml) was added to the medium, and the Ca V 2.2 mRNA levels were measured at the times shown after this. The numbers of determinations from individual oocytes are between 6 and 12 for each data point; *p Ͻ 0.05 compared with Ca V 2.2 (Student's t test). The lines are apparent linear fits using errors as weight. B, Bar chart showing the percentage of Ca V 2.2, ␣2␦-2, and KCC1 mRNA present at time t after actinomycin D addition at time T 0 . For Ca V 2.2 mRNA turnover, t ϭ 9 h. Bars 1-3 are control (black bar; n ϭ 11); ϩ ␥7 (white bar, n ϭ 7) and ϩ ␥7(1-217) (hatched bar; n ϭ 8). Bars 4 -7 show the percentage of ␣ 2 ␦-2 mRNA and KCC1 mRNA present 9 and 24 h, respectively, after actinomycin D addition for the control condition (black bar; n ϭ 8 and 9), ϩ ␥7 (white bar; n ϭ 9 and 9). These times were chosen as the percentage of mRNA remaining in control conditions was similar for all mRNA species. *p Ͻ 0.05 compared with control, Student's t test. C, Degradation rate for endogenous Ca V 2.2 in the ␥7-CFP PC12 cell line (E; n ϭ 3) compared with control pcDNA3.1-transfected PC12 cell line (f; n ϭ 5), after differentiation with NGF. The Ca V 2.2 mRNA level is expressed as percentage of time 0 (T 0 ), when actinomycin D was added. The half-life for endogenous Ca V 2.2 mRNA was 19.5 h in the pcDNA3.1-transfected PC12 cell line. In ␥7-transfected PC12 cells, the half-life was 9.1 h (**p Ͻ 0.01, Student's t test). Inset, Reduction of endogenous Ca V 2.2 mRNA level in ␥7-CFP PC12 cell line compared with control pcDNA3.1-transfected PC12 cell line. ***p Ͻ 0.001 versus control.
tein. Both ␥7 and ␥7(1-271) produced ϳ70% inhibition of Ca V 2.2 protein, whereas ␥7(1-217) caused no reduction (Fig. 2 B) . The extent to which Ca V 2.2 protein expression was suppressed by ␥7 and its truncated constructs was closely correlated with the degree of inhibition of Ca V 2.2 I Ba observed in Xenopus oocytes (Fig. 2C) . As a control, we showed that expression of an unrelated protein of similar size to ␥7 (K V 3.1b) had no effect on Ca V 2.2 protein expression (Fig. 2 B) .
␥7 markedly reduces the stability of Ca V 2.2 mRNA Several mechanisms could underlie the suppression of Ca V 2.2 currents and Ca V 2.2 protein by ␥7, including suppression of channel translation, more rapid protein degradation, suppression of channel transcription, or increased mRNA breakdown. We addressed this question by examining the effect of ␥7 on the level and stability of Ca V 2.2 mRNA. We found that coexpression of ␥7 reduced Ca V 2.2 mRNA levels in two expression systems examined. In COS-7 cells, there was a 64% reduction in Ca V 2.2 mRNA level in the presence of ␥7, 48 h after transfection (supplemental Fig. 3 , available at www.jneurosci.org as supplemental material). In agreement with this, when Ca V 2.2 and ␥7 were coexpressed in individual Xenopus oocytes, there was a 66% reduction in Ca V 2.2 mRNA expression after 24 h (Fig. 3A , see time 0) when compared with control. We then examined whether this was attributable to an increase in the rate of degradation of Ca V 2.2 mRNA. The transcription inhibitor actinomycin D was applied 24 h after injection of the relevant cDNAs into Xenopus oocytes (at time T 0 ), and mRNA levels were then determined in individual oocytes at times up to 24 h thereafter. The half-life of Ca V 2.2 mRNA was 7.8 Ϯ 1.5 h under control conditions (in agreement with Schorge et al., 1999) , and it showed more than a twofold decrease to 3.5 Ϯ 1.1 h in the presence of ␥7 (Fig. 3 A, B) . Importantly, the truncated ␥7(1-217) construct, lacking the C terminus, had no effect on Ca V 2.2 mRNA degradation rate (Fig. 3 A, B ), in agreement with its lack of effect on Ca V 2.2 currents or Ca V 2.2 protein (Figs. 1, 2) .
The relative mRNA concentrations at 24 h in the absence and presence of ␥7 are in agreement with an effect only on the degradation rate of Ca V 2.2 mRNA and not on its synthesis rate. Fitting the data to the rate constants for RNA synthesis and degradation, respectively, (Ϫk d ϫ t) ). From the calculated values of k d , k f ϭ 10.1 and 8.8%/h in the absence and presence of ␥7, respectively, relative to the control Ca V 2.2 mRNA level at 24 h, immediately before actinomycin D treatment. Thus, the data provide no evidence of a marked effect of ␥7 on the synthesis rate (k f ) of Ca V 2.2 mRNA, despite a more than twofold increase in the measured degradation rate.
The effect of ␥7 on mRNA stability does not affect all calcium channel subunits, because the degradation rate of ␣2␦-2 mRNA was not affected by ␥7 coexpression (half-life of ϳ25 h) (Fig. 3B ) (supplemental Fig. 4 A, available at www.jneurosci.org as supplemental material). In agreement with this, the level of ␣2␦-2 protein was little affected by ␥7 (14.9 Ϯ 2.8% reduction; n ϭ 6) (supplemental Fig. 4 B, available at www.jneurosci.org as supplemental material).
We also investigated the effect of ␥7 on the stability of KCC1 mRNA (a potassium chloride cotransporter), because it is a membrane protein of similar mass to Ca V 2.2, whose mRNA has some common sequence motifs (see below). Although KCC1 mRNA was much more stable than that of Ca V 2.2 (half-life of 50.5 h), ␥7 decreased its half-life to 18.3 h, thus increasing its mRNA turnover from 28 Ϯ 11 to 63 Ϯ 5% in 24 h (n Ն 9) (Fig.  3B ). Using the method described above, again we found no evidence for any effect on the synthesis rate. The k f was calculated to be 5.0 and 4.1%/h in the absence and presence of ␥7, respectively, relative to the control KCC1 mRNA level at 24 h. These results indicate that the effect of ␥7 on mRNA degradation rate is selective for certain mRNAs but not selective for Ca V ␣1 mRNAs.
In addition, we demonstrated that ␥7 had the same effect on endogenous Ca V 2.2 mRNA, because, 9 h after actinomycin D treatment, the Ca V 2.2 mRNA level in a PC12 cell line stably transfected with ␥7-CFP was reduced by 74% compared with a control PC12 cell line stably transfected with pcDNA3.1 (Fig. 3C,  inset) , and the endogenous Ca V 2.2 mRNA turnover rate was correspondingly enhanced (Fig. 3C) . The half-life of Ca V 2.2 mRNA was 19.5 h in the pcDNA3.1-transfected PC12 cell line, which was not significantly different from that in control PC12 cells (16.9 h; data not shown). In ␥7-transfected PC12 cells the half-life was 9.1 h (Fig. 3C) .
We found no evidence that the effect of ␥7 involves the induction of ER stress or the unfolded protein response, although this has been postulated as a mechanism of action of TARP ␥2 (Sandoval et al., 2007) . Coexpression of Ca V 2.2 with ␥7 in tsA 201 cells, at a high transfection efficiency using Amaxa nucleofection, did not increase the editing of the X binding protein XBP or induce the C/EBP homologous protein CHOP expression, both of which are markers of the induction of the unfolded protein response (Harding et al., 2002) , whereas these responses were evoked by exposure of cells to tunicamycin or dithiothreitol, both of which are well known activators of ER stress (D. J. Cox and A. C. Dolphin, unpublished results).
Knockdown of ␥7 increases endogenous Ca V 2.2 mRNA level in PC12 cells
To study the physiological role of endogenous ␥7, we chose to silence its expression using RNA interference. We first examined the presence and localization of native ␥7 in PC12 cells. Immunocytochemical localization showed that endogenous ␥7 is expressed in these cells (Fig. 4 A) (supplemental Fig. 5 , available at www.jneurosci.org as supplemental material). We therefore used this cell line to examine the effect of knockdown of ␥7. We designed three shRNAs specifically complementary to sequences in either rat or human ␥7 mRNA. To confirm the effectiveness of the ␥7 shRNAs, we made a PC12 cell line overexpressing human ␥7-CFP and showed that, 5 d after transfection, a mix of three shRNAs directed against human ␥7 mRNA reduced the ␥7-CFP protein level in this cell line, by 75% compared with control transfected cells (Fig. 4 B, C) . We also found the three corresponding rat ␥7 shRNAs reduced endogenous ␥7 mRNA levels in PC12 cells, either individually or when mixed, whereas the control Drosophila gnu shRNA did not (Fig. 4 D) . This would represent a larger reduction in individual transfected cells, taking into account the incomplete transfection efficiency (ϳ30%). Furthermore, the native ␥7 protein present endogenously in PC12 cells (Fig. 4 A, E) was depleted by 70 Ϯ 6% in individual PC12 cells, after transfection with the rat ␥7 shRNAs (Fig. 4 E, F ) .
If ␥7 is playing a physiological role in controlling mRNA stability, its knockdown might be expected to have an effect opposite to ␥7 overexpression, to increase the endogenous Ca V 2.2 mRNA level and enhance its stability. This was indeed the case, because Ca V 2.2 mRNA levels were increased by ϳ30% after rat ␥7 shRNA transfection (Fig. 5A) , which would represent a larger enhancement in individual transfected cells, taking into account the transfection efficiency. An expected physiological correlate of this would be an increase in calcium channel currents in differentiated PC12 cells. In agreement with this, we recorded a 33.1 Ϯ 4.1% (n ϭ 48) increase in peak somatic calcium channel current density in PC12 cells transfected with rat ␥7 shRNAs over the same timescale (Fig. 5B) . . Short-hairpin RNA constructs enhance endogenous Ca V 2.2 mRNA levels and calcium channel currents in PC12 cells. A, Effect of rat ␥7 shRNA on endogenous Ca v 2.2 mRNA level in PC12 cells. Ca v 2.2 mRNA was quantified by q-PCR in PC12 cells transfected with GFP (white bar), negative control shRNA (Ctrl, black bar), or ␥7 shRNAs: ␥7 96 (gray bar), ␥7 285 (hatched bar), ␥7 500 (cross-hatched bar), or ␥7 mix (striped bar). ***p Ͻ 0.001 versus control. B, Top, Representative traces of peak calcium channel currents recorded from differentiated PC12 cells transfected with control shRNA (left) and ␥7 shRNA (right). Currents were elicited by a 100 ms depolarization step to ϩ10 mV from a holding potential of Ϫ100 mV. Bottom, Current-voltage relationships for the two conditions (f, Ctrl shRNA; E, ␥7 shRNA). The charge carrier was 10 mM Ba 2ϩ . The knockdown of ␥7 induces an increase of the peak current (Ϫ16.1 Ϯ 0.9 pA/pF; n ϭ 48) compared with control (Ϫ12.5 Ϯ 0.9 pA/pF; n ϭ 17; p Ͻ 0.05).
␥7 exists in a complex with RNA binding proteins Because PC12 cells contain endogenous ␥7, they represent a suitable model cell type in which to search for protein complexes containing ␥7. For this study, we used a PC12 cell line stably expressing ␥7 with a C-terminal HA tag. After immunoprecipitation of ␥7-HA from the ␥7-HA PC12 cell line and extensive washing, the presence of coimmunoprecipitating proteins, representing proteins in a complex with ␥7, was examined by SDS-PAGE (Fig.  6 A) . Bands of interest, which were present in the ␥7-HA immunoprecipitate but absent from the control, nontransfected PC12 cells (Fig. 6 A, left, arrows, representative of 3 experiments), were excised and identified, after tryptic digestion, by peptide mass fingerprinting. The bands labeled (1, 36 kDa) and (2, 37 kDa) were both identified, with 34 and 38% peptide coverage, respectively, to be hnRNP A2, which has a number of splice variants of 33-38 kDa (Hatfield et al., 2002) . Band 2 also contained hnRNP A3 (40% coverage), which shares extensive sequence homology and is found in a complex with hnRNP A2 (Ma et al., 2002) . The presence of ␥7-HA was confirmed by immunoblotting (Fig. 6 A, right) . Both hnRNP A2 and hnRNP A3 are members of the hnRNP A/B subfamily.
We then confirmed that immunoprecipitation of ␥7-HA was able to pull down endogenous hnRNP A/B proteins in another system, tsA 201 cells transiently transfected with ␥ 7 -HA (Fig. 6 B) . Three bands were detected (36 -42 kDa), using hnRNP A/B Abs, which, according to the antibody specificity and molecular weights, are likely to represent one or more of hnRNP A1, A2, and A3, all of which also have splice variants. No hnRNP A/B immunoreactivity was immunoprecipitated by ␥7(1-217)-HA, under the same conditions (Fig. 6 B) , indicating that these hnRNPs use the C terminus of ␥7 for this interaction. This is in agreement with our previous finding that the C terminus of ␥7 is essential for its functional effects. No hnRNP A/B immunoreactive proteins were coimmunoprecipitated with an un- (top, red; bottom, green) . ii, Localization of ␥7-CFP (top, blue) or immunolocalization of endogenous ␥7 (bottom, red). iii, Merger of images of i and ii, with the colocalized regions shown in white (top) or yellow (bottom). iv, Colocalized ␥7 and hnRNP A2 pixels are also shown separately for clarity (white). Scale bar, 10 m (applies to all images). No endogenous ␥7 staining was observed in the absence of primary Ab (data not shown).
related HA-tagged protein, HA-Ca V ␤1b (Fig. 6C) , indicating that the HA tag is not responsible for this binding.
We also found that pull down of endogenous ␥7 from untransfected PC12 cells, with the ␥7 C-terminal Ab, was able to immunoprecipitate endogenous hnRNP A2 (Fig. 6 D) .
The C terminus of hnRNP A2 interacts directly with the C terminus of ␥7
To determine whether the interaction between ␥7 and hnRNP A2 was direct, we used the yeast two-hybrid technique. When the ␥7 C terminus (residues 201-275) was used as bait, we found an interaction with the C terminus of hnRNP A2 (residues 178 -342) (Fig. 6 E, lane 2) . Because of our previous work in this area, we used the high-affinity (ϳ10 nM) (Leroy et al., 2005) interaction between the I-II linker of Ca V 2.2 and the Ca V ␤1b subunit as a positive control (Fig. 6 E, lane 1) . According to the relative time taken for colonies to turn blue in a colony-lift filter assay, the interaction between hnRNP A2 and ␥7 C terminus is weaker than that between Ca V 2.2 and Ca V ␤1b (data not shown). As negative controls, we showed that there was no interaction between the C termini of either hnRNP A2 or ␥7 and Ca V ␤1b (Fig. 6 E, lanes 3,  4) . Furthermore, the N terminus of hnRNP A2 (amino acids 1-86) was found not to interact with the C terminus of ␥7 (data not shown). All these data indicate that ␥7 is likely to be present in a complex with hnRNP A2. Nevertheless, we cannot rule out that hnRNP A3, which shows marked homology to hnRNP A2, also interacts with ␥7, either directly or by binding to hnRNP A2.
hnRNP A2 colocalizes with ␥7 in neuronal cytoplasm
We used immunocytochemistry to examine whether ␥7 and hnRNP A2 are colocalized in SCG neurons. Although, as expected, most hnRNP A2 is localized in the nucleus, it is also observed in small cytoplasmic granules in SCG neurons (Fig.  6 Fi) . In the somatic cytoplasm, there are clear regions of colocalization of both transfected ␥7-CFP and endogenous ␥7 with hnRNP A2 (Fig. 6 Fii,Fiii) . This is in agreement with our suggestion that ␥7 may sequester free hnRNP A2, as outlined in Figure  9 , A and B.
Ca V 2.2 mRNA binds to hnRNP A2
The hnRNP A2 proteins are highly expressed in brain and are primarily present in the nucleus, in which they bind to particular nucleotide sequences in mRNA. The combination of mRNA with its many bound proteins, including hnRNP A2, then exits the nucleus as ribonucleoprotein particles (Piñol-Roma, 1997) . The interaction with hnRNP A2 has been found to stabilize certain mRNAs for trafficking to a remote site of protein synthesis (Hoek et al., 1998 ) and also to enhance translation (Kwon et al., 1999) . In neurons and oligodendrocytes, hnRNP A2 has been implicated in the transport of mRNAs containing an A2 response element (A2RE) sequence, for local protein synthesis (Hoek et al., 1998; Shyu and Wilkinson, 2000) .
We therefore examined whether Ca V 2.2 mRNA could be present in a complex with hnRNP A2. We found that the Ca V 2.2 mRNA used in this study contains at least two highly conserved sequences predicted to bind hnRNP A2 (Table 1) , from the consensus sequence identified in myelin basic protein (MBP) mRNA (Ainger et al., 1997) . These two sequences are in constitutive exons, present in all splice variants of Ca V 2.2. The sequences preserve A and G at positions 8 and 9, shown previously to be essential for hnRNP A2 binding and function (Ainger et al., 1997; Shan et al., 2003) , and the sequences are highly conserved in Ca V 2.2 between species (Table 1) , with related sequences being found in Ca V 2.1 (data not shown). We found that a biotinylated 21 base ribonucleotide corresponding to sequence 1 from Ca V 2.2 (Table 1) binds endogenous hnRNP A2 from a mouse brain lysate, to a similar extent to the sequence originally described from MBP (Hoek et al., 1998) (Fig. 7A ). We further found that an anti-HA Ab coimmunoprecipitated N-terminally HA-tagged hnRNP A2, both with overexpressed full-length rabbit Ca V 2.2 mRNA in tsA 201 cells (data not shown) and also with endogenous Ca V 2.2 mRNA in PC12 cells (Fig. 7B) . Furthermore, an anti-hnRNP A2 monoclonal Ab coimmunoprecipitated endogenous hnRNP A2 together with endogenous Ca V 2.2 mRNA from PC12 cells (Fig. 7C). hnRNP A2 enhances the expression of Ca V 2.2 currents, and this is counteracted by ␥7 Because hnRNP A2 binds to Ca V 2.2 mRNA, we wanted to examine the consequences on calcium channel expression of coexpression with hnRNP A2. When this construct was coexpressed with Ca V 2.2/␤1b/␣2␦-2 in Xenopus oocytes, it produced a significant enhancement of the peak calcium current amplitude, without affecting the current kinetics or voltage dependence (Fig. 7D) . In experiments performed in parallel, an unrelated hnRNP (A1), which is involved in mRNA processing and export but does not bind to A2RE sequences (Cullen, 2000) , did not enhance Ca V 2.2 calcium currents (Fig. 7D) . Thus, hnRNP A2 may enhance Ca V 2.2 mRNA stability in Xenopus oocytes or increase its transport to sites of translation. This is compatible with the role previously attributed to hnRNP A2 that it enhances both transport and translation of specific mRNAs (Kwon et al., 1999) . We also found that the effect of hnRNP A2 was able to generalize to other Ca V 2 channels, because enhancement of Ca V 2.1/␤4/␣2␦-2 currents was also observed, the peak I Ba at ϩ5 mV being increased to 194.8 Ϯ 19.9% of control (n ϭ 28; p ϭ 0.0004). Ca V 2.1 mRNA contains A2RE sequences that are homologous to those of Ca V 2.2 (data not shown).
We then investigated whether there was an interaction between the effects of hnRNP A2 and ␥7 on calcium channel current expression. The inhibitory effect of ␥7 on Ca V 2.2 calcium channel currents, shown in Figure 1 B, was found to be concentration dependent (data not shown), and a low concentration of ␥7 was chosen (1:4 dilution of ␥7 cDNA), which did not inhibit Ca V 2.2 currents in the Xenopus oocyte expression system (Fig.  7E) , to examine its interaction with the effect of hnRNP A2. We found that the enhancement of Ca V 2.2 currents by hnRNP A2 was prevented by coexpression of this low concentration of ␥7 The binding motif identified in MBP (Hoek et al., 1998 ) is compared with the two found in Ca V 2.2. The essential conserved AG bases are in bold, and the sequences identical to MBP A2RE are underlined. Exon numbering as shown in ENSEMBL.
( Fig. 7E) . This indicates that ␥7 opposes the effect of hnRNP A2, supporting the hypothesis that the binding of hnRNP A2 to its binding site on the C terminus of ␥7 reduces the amount available to interact with Ca V 2.2 mRNA in the cytosol. In agreement with this interpretation, expression of the cytosolic C terminus of ␥7 [␥7(201-275)], which our yeast twohybrid data show to be able to bind hnRNP A2 (Fig. 6 E) , was itself able to reduce the amplitude of Ca V 2.2 currents. In experiments similar to those shown in Figure 1 B, the peak Ca V 2.2 I Ba current amplitude was reduced by 70.6 Ϯ 4.5% (n ϭ 19) relative to control currents, in the presence of the C terminus of ␥7 (data not shown) compared with an 87.4% reduction by fulllength ␥7 in the same experiment.
Investigation of the subcellular localization of ␥7
The topology of ␥1 and the TARP ␥ proteins indicates that the linker between the first and second transmembrane domains is extracellular (Chu et al., 2001) , and the same might be anticipated for ␥7, which has a predicted glycosylation site in this loop (Fig. 1 A) . We obtained mutational evidence that ␥7 is N-glycosylated on N45 in the I-II loop, supporting the proposed topology (Fig. 8 A) . However, heterologously expressed ␥7 is not inserted in the plasma membrane of tsA 201 cells, because it was not detected with an Ab to this I-II loop in nonpermeabilized cells (Fig. 8 B) . We have observed that ␥7-CFP, when heterologously expressed in cultured SCG neurons, is present, in part, in motile intracellular vesicles (Fig. 8C and data not shown). These colocalize with ␥7 I-II loop Ab immunoreactivity only when the cells are permeabilized (Fig. 8C) . No plasma Figure 7 . Binding of hnRNP A2 to Ca V 2.2 mRNA and effect of hnRNP A2 and ␥7 on Ca V 2.2 currents. A, Evidence that one of the two potential A2RE sites in Ca V 2.2 mRNA binds to hnRNP A2. Endogenous hnRNP A2 (indicated by the arrow) from mouse brain lysate was pulled down by biotinylated oligonucleotides containing the consensus A2RE site (lane 2) and the potential site in Ca V 2.2 (lane 3) but not by beads alone (lane 1) or by a nonspecific sequence with the same composition as the consensus A2RE site (lane 4). The hnRNP A2 was detected by immunoblotting with anti-hnRNP A2 Ab (F16). Position of molecular weight markers is shown on the left. Representative of two experiments. B, Coimmunoprecipitation of endogenous Ca V 2.2 mRNA associated with hnRNP A2 in PC12 cells. Two days after transfection with HA-hnRNP A2 (HA-A2, lanes 1 and 3) or hnRNP A2 (A2, lanes 2 and 4), hnRNP A2 protein was immunoprecipitated (IP) from the whole-cell lysate (lanes 1 and 2) with HA antibody (lanes 3 and 4) . Immunoblots show that HA Ab pulled down hnRNP A2 [top row, anti-hnRNP A2 (EF-67 Ab); middle row, anti-HA]. Coimmunoprecipitated RNA was extracted, reverse transcribed, and amplified by PCR. A specific PCR product corresponding to the endogenous Ca V 2.2 mRNA was amplified (35 cycles) only in the condition in which hnRNP A2 protein was pulled down (bottom row, lane 3). C, Left, Endogenous hnRNP A2 proteins were immunoprecipitated from PC12 cells with anti-hnRNP A2 Ab EF-67 (top row, lane 2). In this condition, a specific PCR product corresponding to the endogenous Ca V 2.2 mRNA was also amplified (35 cycles, bottom row). Ca V 2.2 mRNA was not detected in the control in which antibody was omitted (lane 3). Right, The immunoprecipitation was repeated, including an acetone precipitation step, to confirm the presence of endogenous hnRNP A2. D, Enhancement by hnRNP A2 but not hnRNP A1 of Ca V 2.2 currents recorded from Xenopus oocytes. Left, Example traces elicited by 50 ms step depolarizations to between Ϫ40 and 0 mV in 10 mV steps, from a holding potential of Ϫ100 mV for Ca V 2.2/␤1b/␣2␦-2 (top traces) or Ca V 2.2/␤1b/␣2␦-2 plus hnRNP A2 (bottom traces). The charge carrier was 10 mM Ba 2ϩ . Right, Bar chart shows the effect of hnRNP A2 coexpression with Ca V 2.2/␤1b/␣2␦-2 on peak Ca V 2.2 I Ba amplitude, expressed relative to the mean peak control current in each experiment. Control (black bar; n ϭ 18), for both groups taken from experiments directly comparing hnRNP A1 and hnRNP A2: ϩ hnRNP A2 (white bar; n ϭ 21) and ϩ hnRNP A1 (hatched bar; n ϭ 19). These data are pooled from two separate 4 experiments showing similar results. Statistical significance, *p Ͻ 0.05, **p Ͻ 0.01 (one-way ANOVA and Bonferroni's post hoc test). E, Inhibition of the hnRNP A2-mediated enhancement of I Ba in Xenopus oocytes by a low concentration of ␥7. Bar chart compares the effect of two concentrations of ␥7 cDNA (␥7: Ca V 2.2 ratio 1 and 0.25) and also shows the lack of enhancement by hnRNP A2 on peak Ca V 2.2 I Ba amplitude, when coexpressed with the lower concentration of ␥7 (␥7: Ca V 2.2 ratio 0.25). Data are expressed as a percentage of the mean peak control Ca V 2.2 current in each experiment, and all data were recorded 2 d after cDNA injection. Control in the absence of ␥7 or hnRNP A2 (white bars); ϩ ␥7 (ratio 1; hatched bar), ϩ ␥7 (ratio 0.25; cross-hatched bar), ϩ hnRNP A2 (black bar, from data obtained in the same experiments), ϩ hnRNP A2 and ␥7 (ratio 0.25; gray bar). Number of determinations given above each bar. These data are pooled from five different batches of oocytes, in all of which similar results were observed. Statistical significance, **p Ͻ 0.01 (one-way ANOVA and Bonferroni's post hoc test).
membrane staining was detected in the absence of cell permeabilization (Fig. 8C) . We also found that neither endogenous ␥7 (Fig. 4 A) nor ␥7-CFP (Fig. 4 B and data not shown) localized to the plasma membrane in PC12 cells. The localization of ␥7 is therefore on intracellular membranes in all the cells we have examined. We found that the distribution of ␥7-CFP partially overlapped with that of an ER marker in the somata of SCG neurons microinjected with ␥7-CFP and pDsRed2-ER (Fig. 8 D) . It was also found in vesicular structures, which were negative for the ER marker (Fig. 8 D) . Similar results were obtained in PC12 cells using a different ER marker, protein disulfide isomerase (data not shown).
Discussion
We have described previously the identification of two genes that encode ␥5 and ␥7, by their homology with the mouse stargazin gene (cacng2) and have cloned and expressed the cDNA for both human and mouse ␥7 . The ␥7 protein contains 275 amino acids with an estimated protein mass of 31 kDa and has four predicted transmembrane-spanning domains with intracellular N and C termini and a consensus N-glycosylation sequence in the loop between the first two transmembrane segments (Fig. 1 A) . Together with the other ␥-like proteins, it belongs to the claudin superfamily, members of which play diverse roles in cellular physiology (Sanders et al., 2001) . Initially, the novel ␥1-like proteins (␥2-␥8) were investigated as potential calcium channel subunits (Letts et al., 1998; Klugbauer et al., 2000; Kang et al., 2001; Rousset et al., 2001; Sharp et al., 2001; Moss et al., 2003) . However, we have shown that, although the human ␥2 and ␥4 TARPS are expressed in Purkinje neurons, there was no effect of these proteins on calcium currents composed of Ca V 2.1/␤4/␣2␦-2, a combination that mimics the major calcium channel complement in Purkinje cells (Moss et al., 2003) . More recently, these proteins have been shown to have roles in trafficking and localization of AMPA glutamate receptors (Tomita et al., 2003 (Tomita et al., , 2004 Fukata et al., 2005; Kato et al., 2007) . Together with the data presented here, these findings suggest that ␥ proteins may play diverse and possibly multiple roles in intracellular trafficking.
In our original study, we showed that coexpression with ␥7 almost completely abolished Ba 2ϩ current through N-type Ca V 2.2 channels expressed from cDNA in both Xenopus oocyte and COS-7 cell expression systems . Several mechanisms could underlie the suppression of Ca V 2.2 currents by ␥7 protein, but we have now identified that a major mechanism of suppression of Ca V 2.2 currents by ␥7 results from a decrease in Ca V 2.2 mRNA stability. This process requires the cytoplasmic C terminus of ␥7, because all its effects, to inhibit Ca V 2.2 current and protein expression and to increase the rate of mRNA degradation, are completely prevented by the removal of most of the C terminus of ␥7. It is well known that the effect of overexpression of a protein does not necessarily reflect its physiological function, because an overexpressed protein may act to sequester interacting partners. However, our evidence indicates that the regulation of the stability of Ca V 2.2 mRNA, and potentially other mRNAs, represents an important role for native ␥7. This evidence stems from the finding that knockdown of endogenous ␥7 in PC12 cells, using ␥7 shRNA, substantially en- hances their endogenous Ca V 2.2 mRNA level and enhances endogenous somatic calcium currents after differentiation.
We have subsequently identified by coimmunoprecipitation from a PC12 cell line stably transfected with ␥7-HA, that the RNA binding protein hnRNP A2 is coimmunoprecipitated with ␥7. hnRNP A2 has been found to be involved in the stability, trafficking, and localization of particular mRNAs and has been identified to bind to several different mRNA sequences, including CGG repeats (Sofola et al., 2007) , AU-rich elements (Hamilton et al., 1999) , and a well characterized binding motif termed A2RE (Ainger et al., 1997; Shan et al., 2003; Fähling et al., 2006) . Most hnRNP A2 is localized in the nucleus, in which it binds to specific sequences in transcribed mRNA, and is involved in mRNA export into the cytoplasm (for review, see Shyu and Wilkinson, 2000) and subsequently in trafficking and enhancement of translation for those mRNAs containing an A2RE sequence (Kwon et al., 1999) . Our yeast two-hybrid data indicates that ␥7 C terminus binds directly to hnRNP A2, and our subcellular localization data for ␥7 indicate that this interaction will occur on intracellular membranes within the cytoplasm (as depicted in Fig. 9B ).
There are two highly conserved consensus hnRNP A2-binding A2RE motifs in the Ca V 2.2 mRNA used in this study ( Table 1) that contain the conserved A and G at positions 8 and 9, which have been found to be a prerequisite for binding of hnRNP A2 (Ainger et al., 1997) . There are also several other, less well conserved, A2RE motifs in the Ca V 2.2 mRNA sequence that may also be functional (data not shown). Here we have demonstrated that hnRNP A2 binds to one of the conserved sequences (Table 1, sequence 2) and, by homology, is highly likely to bind to the other sequence. Furthermore, hnRNP A2 coimmunoprecipitates endogenous Ca V 2.2 mRNA from PC12 cells. We suggest that hnRNP A2 normally binds to sequences on Ca V 2.2 mRNA in the nucleus, and, when the ribonucleoprotein particle so formed exits the nucleus, it is transported to its site of translation and also protected from degradation (as depicted in Fig. 9A) . A similar mechanism of interaction with hnRNP A2 has been proposed for MBP mRNA that contains a canonical A2RE sequence (Hoek et al., 1998) . It has also been shown that hnRNP A2 itself is subject to transport (Brumwell et al., 2002) . Indeed, the hnRNP A/B proteins have been identified as components in isolated RNAtransporting granules (Kanai et al., 2004) . Furthermore, the Drosophila homolog Hrp48 is involved in the localization of oskar mRNA (Huynh et al., 2004; Yano et al., 2004) . Other RNA binding proteins, such as Staufen, have been shown to have an effect on both localization and decay of specific mRNAs (Broadus et al., 1998; Kim et al., 2005) .
Our results provoke the hypothesis that ␥7 is involved in the regulation of hnRNP A2 function, as depicted in Figure 9B . ␥7 may sequester hnRNP A2, and this may be the mechanism whereby the stability of specific mRNAs, including that of Ca V 2.2, are compromised. Furthermore, our results indicate that native, as well as heterologously expressed, ␥7 both influence the physiological regulation of Ca V 2.2 mRNA stability, because knockdown of native ␥7 increased endogenous Ca V 2.2 mRNA and Ca V 2.2 current levels. This indicates that endogenous ␥7 may function to limit the availability of cytoplasmic hnRNP A2. A related pathological mechanism of hnRNP A2 sequestration by binding to expanded CGG repeats of FMR1 mRNA has been proposed recently to occur in fragile X-associated tremor/ataxia syndrome (Sofola et al., 2007) . It will be of interest to examine whether a similar interaction occurs with other triplet repeat diseases.
The expression of Ca V 2.2 channel proteins may be particularly vulnerable to a reduction in available hnRNP A2 because the mRNA degradation rate of Ca V 2.2 is relatively high. Nevertheless, other mRNAs are also likely to be similarly affected, and we show that the degradation of KCC1 mRNA, which also contains an A2RE sequence, is also enhanced by ␥7.
Both Ca V 2.2 (Mori et al., 1991) and ␥7 ) are selectively expressed in neurons. Ca V 2.2 channel expression and function is dynamically regulated both physiologically (Pravet- Figure 9 . Diagram of proposed function of ␥7. A, The physiological distribution of hnRNP A2 and ␥7. The hnRNP A2 (red circles) is localized primarily in the nucleus in which it binds to A2RE sequences on mRNAs and exits to the cytoplasm with these mRNAs, including that of Ca V 2.2 (green). This is thought to stabilize certain mRNAs, reducing degradation and therefore enhancing expression. Our results suggest this may be the case for Ca V 2.2. hnRNP A2 may also stabilize the mRNAs for transport. ␥7 (dark blue) is present on the ER and is also associated with motile vesicles. B, After overexpression of ␥7, it may sequester cytoplasmic hnRNP A2 and therefore increase degradation of Ca V 2.2 mRNA. toni et al., 2000; Inchauspe et al., 2004) and in pathology (Hendriksen et al., 1997) . It is of interest that Ca V 2.2 channels are functionally most important in early development, and, in many instances, their role is later substituted by P/Q-type calcium channels (Ca V 2.1), in terms of both somatic currents (Salgado et al., 2005) and synaptic transmission (Iwasaki et al., 2000) . Over a similar time period, we found that ␥7 expression is strongly upregulated (M. Nieto-Rostro and A. C. Dolphin, unpublished results). It is now recognized from many studies that regulation of mRNA stability is a very important part of the posttranscriptional control of expression of numerous genes (Wilusz and Wilusz, 2004) .
There are indications that Ca V 2.2 mRNA is subject to transport, because it has been identified in dendritic growth cones (Crino and Eberwine, 1996) and in processes of motor neurons (Jablonka et al., 2007) . Furthermore, N-type calcium channels are localized in the presynaptic terminals of peripheral neurons, such as DRG neurons, and local synthesis of transmembrane proteins has been demonstrated recently in axons and axonal growth cones (Brittis et al., 2002) . It will be of great interest in the future to examine whether hnRNP A2 affects the transport of Ca V 2 family mRNAs, to regions distinct from the cell soma.
